Equillium, Inc 8-K, filed May 28, 2021
Equillium, Inc. (EQ)
About this 8-K
Equillium, Inc filed this 8-K on May 28, 2021, reporting on events of May 26, 2021.
Items reported
- Item 5.07: Shareholder vote results
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): |
(Exact name of Registrant as Specified in Its Charter)
(State or Other Jurisdiction |
(Commission File Number) |
(IRS Employer |
||
|
|
|
|
|
|
||||
|
||||
(Address of Principal Executive Offices) |
|
(Zip Code) |
||
Registrant’s Telephone Number, Including Area Code: |
|
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Securities registered pursuant to Section 12(b) of the Act:
|
|
Trading |
|
|
|
|
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Item 5.07 Submission of Matters to a Vote of Security Holders.
On May 26, 2021, Equillium, Inc. (the “Company”) held its annual meeting of stockholders (the “Annual Meeting”). As of April 1, 2021, the record date for the Annual Meeting, 29,040,270 shares of the Company’s common stock were outstanding and entitled to vote at the Annual Meeting. The following is a brief description of each matter voted upon at the meeting and the number of votes cast for, withheld or against, the number of abstentions and the numbers of broker non-votes with respect to each matter, as applicable.
A total of 24,310,147 shares of the Company’s common stock were present at the Annual Meeting in person or by proxy, which represents approximately 83.71% of the shares of the Company’s common stock outstanding as of the record date for the Annual Meeting.
1. To elect the following two Class III directors for a three-year term to expire at the 2024 annual meeting of stockholders and until their successors are duly elected and qualified:
Nominee |
Shares Voted For |
Voting Authority Withheld |
Broker Non-Votes |
Daniel M. Bradbury |
14,661,923.66 |
3,581,415.74 |
6,066,808.00 |
Martha J. Demski |
14,661,415.01 |
3,581,924.39 |
6,066,808.00 |
Mark Pruzanski, M.D. |
14,667,052.01 |
3,576,287.39 |
6,066,808.00 |
In accordance with the above results, each nominee was elected to serve as a director.
2. To ratify the appointment of KPMG LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2021:
Shares Voted For |
Shares Voted Against |
Abstain |
Broker Non-Votes |
24,004,612.40 |
300,425.00 |
5,110.00 |
0.00 |
In accordance with the above results, the selection of KPMG LLP was approved.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
|
|
|
Equillium, Inc. |
|
|
|
|
Date: |
May 28, 2021 |
By: |
/s/ Bruce D. Steel |
|
|
|
Bruce D. Steel |